Lineage Cell Therapeutics, Inc. Payments to Acquire Businesses, Gross
Lineage Cell Therapeutics, Inc. (LCTX) reported Payments to Acquire Businesses, Gross of $0 for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesGross · last filed 2011-11-08
- Lineage Cell Therapeutics, Inc. payments to acquire businesses, gross for the quarter ending 2011-09-30 was $0.00.
- Lineage Cell Therapeutics, Inc. payments to acquire businesses, gross for the quarter ending 2010-09-30 was $0.00.
| Period end | Payments to Acquire Businesses, Gross 3 month | Payments to Acquire Businesses, Gross 6 month | Payments to Acquire Businesses, Gross 9 month |
|---|---|---|---|
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $0.00 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-09 | ||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$80.00K 10-Q · filed 2011-11-08 | |
| 2010-06-30 | -$80.00K 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |